HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.

MLA

Gilles, Christine, et al. “HPV Genotyping in Biopsies of HSIL and Invasive Cervical Cancers in Women Living with HIV: A Cohort- and a Nested -Case Control Study.” Vaccine, vol. 40, no. 50, Nov. 2022, pp. 7230–37. EBSCOhost, https://doi.org/10.1016/j.vaccine.2022.10.029.

APA

Gilles, C., Rozenberg, S., Buxant, F., Manigart, Y., de Wind, R., Houte, K. V., Vandenbroeck, D., Delforge, M., & Konopnicki, D. (2022). HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study. Vaccine, 40(50), 7230–7237. https://doi.org/10.1016/j.vaccine.2022.10.029

Chicago

Gilles, Christine, Serge Rozenberg, Frederic Buxant, Yannick Manigart, Roland de Wind, Katherina Vanden Houte, Davy Vandenbroeck, Marc Delforge, and Deborah Konopnicki. 2022. “HPV Genotyping in Biopsies of HSIL and Invasive Cervical Cancers in Women Living with HIV: A Cohort- and a Nested -Case Control Study.” Vaccine 40 (50): 7230–37. doi:10.1016/j.vaccine.2022.10.029.